A HALF-HOUR scan could help bladder cancer patients be treated almost twice as fast, a groundbreaking study has found. Using an MRI check to help tackle tumours — instead of invasive surgery — cut

Researchers have introduced an innovative surgical technique for treating bladder cancer that could revolutionize the field of urological oncology.

Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in the UK

Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder cancer. Using the immunotherapy drug durvalumab before and after surgery reduced the recurrence of operable bladder cancer by a third,

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth?

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms might seem minor, understanding

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click for our IBRX stock update.

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also being trialled in other cancers.

Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or mpMRI-staged care.

They hope it will be approved by the Medicines and Healthcare Products Regulatory Agency to become the new standard of care. James Douglas, consultant urologist at Nuffield Health Bournemouth Hospital said: "Cancer of the bladder involves abnormal growths that can cause symptoms both within the bladder and beyond if it spreads around the body.

A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the disease returning by a third...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...